OrbiMed Adjusts Stake in Disc Medicine with $16.97M Sale OrbiMed Advisors LLC has sold $16.97 million worth of Disc Medicine shares, executed between March 10 and March 12, 2025. The transactions occurred at prices ranging from $54.01 to $55.05 per share. Despite the sale, OrbiMed retains a significant holding in the company, which analysts view with optimistic price targets.12